{"id":13098,"date":"2023-05-04T04:30:00","date_gmt":"2023-05-04T08:30:00","guid":{"rendered":"https:\/\/dbv-technologies.com\/press_releases\/dbv-technologies-publie-ses-resultats-financiers-du-premier-trimestre-2023\/"},"modified":"2023-05-04T04:30:00","modified_gmt":"2023-05-04T08:30:00","slug":"dbv-technologies-publie-ses-resultats-financiers-du-premier-trimestre-2023","status":"publish","type":"press_releases","link":"https:\/\/dbv-technologies.com\/fr\/press_releases\/dbv-technologies-publie-ses-resultats-financiers-du-premier-trimestre-2023\/","title":{"rendered":"DBV Technologies publie ses r\u00e9sultats financiers du premier trimestre 2023"},"content":{"rendered":"<div class=\"pr-date-globe\">May 04, 2023 16:30 ET<\/div>\n<p>                            <!-- <span>Name:DistributionId<\/span>   <span>Value:1000808299<\/span> -->                            <!-- <span>Name:EnableQuoteCarouselOnPnr<\/span>   <span>Value:True<\/span> -->                            <!-- <span>Name:IcbCode<\/span>   <span>Value:4573<\/span> -->                            <!-- <span>Name:CustomerId<\/span>   <span>Value:1011152<\/span> -->                            <!-- <span>Name:HasMediaSnippet<\/span>   <span>Value:false<\/span> -->                            <!-- <span>Name:AnalyticsTrackingId<\/span>   <span>Value:d1fa04da-82b3-4509-bfef-5e332d562f32<\/span> --><\/p>\n<p align=\"right\">Montrouge, France, May 4 (22h30 CEST) 2023<\/p>\n<p align=\"left\"><strong>DBV Technologies <\/strong><strong>publie ses <\/strong><strong>r\u00e9sultats financiers du premier trimestre 2023<\/strong><\/p>\n<ul type=\"disc\">\n<li style=\"text-align:left;\"><strong>DBV <\/strong><strong>cl<\/strong><strong>\u00f4<\/strong><strong>ture le premier trimestre 2023 avec une position nette de tr\u00e9sorerie <\/strong><strong>de <\/strong><strong>192<\/strong><strong>.<\/strong><strong>3 million<\/strong><strong>s de dollars<\/strong>\n<\/li>\n<\/ul>\n<p align=\"justify\">DBV Technologies (Euronext : DBV \u2013 ISIN : FR0010417345 \u2013 Nasdaq Stock Market : DBVT), soci\u00e9t\u00e9 biopharmaceutique au stade clinique, a annonc\u00e9 aujourd&rsquo;hui ses r\u00e9sultats financiers pour le premier trimestre de 2023. Les \u00e9tats financiers trimestriels ont \u00e9t\u00e9 approuv\u00e9s par le conseil d&rsquo;administration le 4 mai 2023.<\/p>\n<p align=\"justify\"><strong>R\u00e9sultats financiers pour le premier trimestre clos <\/strong><strong>le 31 mars 2023<\/strong><\/p>\n<p align=\"justify\">Les \u00e9tats financiers consolid\u00e9s trimestriels de la Soci\u00e9t\u00e9 se terminant le 31 mars 2023 2022 sont pr\u00e9par\u00e9s conform\u00e9ment aux principes comptables g\u00e9n\u00e9ralement admis aux \u00c9tats-Unis (\u00a0\u00bb U.S. GAAP \u00ab\u00a0).<\/p>\n<p align=\"justify\"><strong>Tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:446.55pt; border-collapse:collapse ;\">\n<tbody>\n<tr>\n<td rowspan=\"2\" style=\"width:368.6px;;text-align: justify ;  vertical-align: middle; vertical-align: middle ; text-align: justify ;  vertical-align: middle; \">En millions de dollars<\/p>\n<p>&nbsp;<\/td>\n<td colspan=\"2\" style=\"width:226.8px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>T<\/strong><strong>rois<\/strong> <strong>mois clos le 31 mars<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>2023<\/strong><\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>2022<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:368.6px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>Tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie nets <\/strong><strong>\u00e0 l\u2019ouverture<\/strong><\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \"><strong>209.2<\/strong><\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \"><strong>77.3<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:368.6px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>Augmentation\/(diminution) de la tr\u00e9sorerie <\/strong><strong>:<\/strong><\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>(16.9)<\/strong><\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>(<\/strong><strong>3.2<\/strong><strong>)<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:368.6px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Flux de tr\u00e9sorerie net li\u00e9 aux activit\u00e9s op\u00e9rationnelles<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(20.8)<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(1.5)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:368.6px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Flux de tr\u00e9sorerie net li\u00e9 aux activit\u00e9s d\u2019investissement<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">&#8211;<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">&#8211;<\/td>\n<\/tr>\n<tr>\n<td style=\"width:368.6px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Flux de tr\u00e9sorerie net li\u00e9 aux activit\u00e9s de financement<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">&#8211;<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(0.1)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:368.6px;;text-align: left ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">Incidence des variations du cours des devises<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">3.9<\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">(1.6)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:368.6px;;text-align: left ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>Tr\u00e9sorerie et \u00e9quivalents de t<\/strong><strong>r\u00e9sorerie nets \u00e0 la cl\u00f4ture<\/strong><\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>192.3<\/strong><\/td>\n<td style=\"width:113.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>7<\/strong><strong>4.1<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"justify\">La tr\u00e9sorerie et les \u00e9quivalents de tr\u00e9sorerie s\u2019\u00e9levaient \u00e0 $192.3 millions au 31 mars 2023 contre $209.2 millions au 31 d\u00e9cembre 2022, soit une diminution nette de $16.9 millions expliqu\u00e9e par&nbsp;:<\/p>\n<p align=\"justify\">(1)&nbsp;&nbsp;&nbsp;$20.8 millions de flux net de tr\u00e9sorerie li\u00e9 aux activit\u00e9s op\u00e9rationnelles, principalement expliqu\u00e9s par l\u2019initiation de l\u2019\u00e9tude VITESSE. La tr\u00e9sorerie nette utilis\u00e9e pour les activit\u00e9s op\u00e9rationnelles a augment\u00e9 de $19.3 millions en comparaison du m\u00eame trimestre en 2022. Au cours du premier trimestre 2022, la Soci\u00e9t\u00e9 a en effet re\u00e7u $20.9 millions de l\u2019administration fiscale fran\u00e7aise pour remboursement des cr\u00e9dits d\u2019imp\u00f4t recherche des exercices 2019 et 2020.<\/p>\n<p>(2)&nbsp;&nbsp;&nbsp;Partiellement compens\u00e9s par $3.9 millions d\u2019incidence positive des variations du cours des devises. La position de tr\u00e9sorerie de la Soci\u00e9t\u00e9, pr\u00e9sent\u00e9e en dollars am\u00e9ricains, a en effet \u00e9t\u00e9 impact\u00e9e par l\u2019appr\u00e9ciation de l\u2019euro contre le dollar au cours du premier trimestre 2023.<\/p>\n<p align=\"justify\"><strong>Produits op\u00e9rationnels<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:441.85pt; border-collapse:collapse ;\">\n<tbody>\n<tr>\n<td style=\"width:283.54px;;text-align: justify ;  vertical-align: middle; vertical-align: middle ; \">En millions de dollars<\/td>\n<td colspan=\"4\" style=\"width:305.6px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>T<\/strong><strong>rois mois clos le 31 mars<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;vertical-align: middle ; \">&nbsp;<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>2023<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>2022<\/strong><\/td>\n<td colspan=\"2\" style=\"width:152.8px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">Variation<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Cr\u00e9dits d\u2019imp\u00f4t recherche<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">1.8<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">1.5<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">+0.3<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">+20%<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">Autres produits op\u00e9rationnels<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">0.4<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">1.0<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">-0.6<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">-60%<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>Produits op\u00e9rationnels<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>2.2<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>2.<\/strong><strong>5<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>-0<\/strong><strong>.<\/strong><strong>3<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>-1<\/strong><strong>2<\/strong><strong>%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"justify\">Les produits op\u00e9rationnels s\u2019\u00e9levaient \u00e0 $2.2 millions au 31 mars 2023 contre $2.5 millions au 31 mars 2022, soit une diminution de $0,3 millions expliqu\u00e9e par&nbsp;:<\/p>\n<p align=\"justify\">(1)&nbsp;&nbsp;&nbsp;Une augmentation de $0.3 millions de l\u2019estimation du cr\u00e9dit d\u2019imp\u00f4t recherche, les frais de recherche et d\u00e9veloppement ayant augment\u00e9 au cours du premier trimestre 2023 par rapport au m\u00eame trimestre 2022, principalement en raison de l\u2019initiation de l&rsquo;\u00e9tude VITESSE.<\/p>\n<p>(2)&nbsp;&nbsp;&nbsp;Partiellement compens\u00e9e par la variation de $0.6 million des autres produits op\u00e9rationnels qui correspondaient aux revenus reconnus \u00e0 l\u2019avancement du contrat de collaboration avec Nestl\u00e9 Health Science .<\/p>\n<p align=\"justify\"><strong>Charges op\u00e9rationnelles<\/strong><strong>&nbsp;<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:441.85pt; border-collapse:collapse ;\">\n<tbody>\n<tr>\n<td style=\"width:283.54px;;text-align: justify ;  vertical-align: middle; vertical-align: middle ; \">En millions de dollars<\/td>\n<td colspan=\"4\" style=\"width:305.6px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>T<\/strong><strong>rois mois clos le 31 mars<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;vertical-align: middle ; \">&nbsp;<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>2023<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>2022<\/strong><\/td>\n<td colspan=\"2\" style=\"width:152.8px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">Variation<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Recherche et d\u00e9veloppement<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">16.0<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">12.2<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">+3.8<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">+31%<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Frais commerciaux<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">0.4<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">0.5<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">-0.1<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">-20%<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">Frais g\u00e9n\u00e9raux<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">6.9<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">6.6<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">+0.3<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">+5%<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>Charges op\u00e9rationnelle<\/strong><strong>s<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>2<\/strong><strong>3.3<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>19.3<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>+4.0<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>+21<\/strong><strong>%<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"justify\">Les charges op\u00e9rationnelles s\u2019\u00e9levaient \u00e0 $23.3 millions au 31 mars 2023 contre $19.3 millions au 31 mars 2022, soit une augmentation de $4.0 millions principalement due aux d\u00e9penses de recherche et d\u00e9veloppement pour soutenir l\u2019initiation de l\u2019\u00e9tude VITESSE.<\/p>\n<p align=\"justify\"><strong>Perte nette et perte n<\/strong><strong>ette par action<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:441.85pt; border-collapse:collapse ;\">\n<tbody>\n<tr>\n<td style=\"width:283.54px;;vertical-align: middle ; \">&nbsp;<\/td>\n<td colspan=\"4\" style=\"width:305.6px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>T<\/strong><strong>rois mois clos le 31 mars<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;vertical-align: middle ; \">&nbsp;<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>2023<\/strong><\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>2022<\/strong><\/td>\n<td colspan=\"2\" style=\"width:152.8px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">Variation<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">R\u00e9sultat net en millions de dollars<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">(20.5)<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">(16.7)<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">-3.8<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">-23%<\/td>\n<\/tr>\n<tr>\n<td style=\"width:283.54px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">R\u00e9sultat de base et dilu\u00e9 par action ($\/action)<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(0.22)<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(0.30)<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">+0.1<\/td>\n<td style=\"width:76.4px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">+27%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"left\">Le r\u00e9sultat du premier trimestre 2023 clos le 31 mars 2023 est une perte nette de $20.5 millions contre une perte nette de $16.7 millions pour le premier trimestre 2022.<\/p>\n<p align=\"left\">La perte nette par action (sur la base du nombre moyen pond\u00e9r\u00e9 d&rsquo;actions en circulation au cours de l\u2019exercice) est de $0.22 pour le premier trimestre 2023.<\/p>\n<p align=\"left\"><strong>ETAT RESUME DE LA SITUATION FINANCIERE CONSOLIDEE<\/strong><strong> (<\/strong><strong>non <\/strong><strong>audit\u00e9<\/strong><strong>)<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:446.55pt; border-collapse:collapse ;\">\n<tbody>\n<tr>\n<td style=\"width:321.34px;;text-align: justify ;  vertical-align: middle; vertical-align: middle ; \">En millions de dollars<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>31<\/strong><strong> mars 2023<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>31 <\/strong><strong>d\u00e9cembre<\/strong><strong> 2022<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>A<\/strong><strong>ctif<\/strong><\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \"><strong>232.9<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \"><strong>246.5<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Dont tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">192.3<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">209.2<\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>Dettes<\/strong><\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>53.8<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>52.1<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>Capitaux propres<\/strong><\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>179.1<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>194.5<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Dont r\u00e9sultat net<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(20.5)<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(96.3)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"left\"><strong>ETAT RESUME DU COMPTE DE RESULTAT ET DU RESULTAT GLOBAL CONSOLIDE <\/strong><strong>(<\/strong><strong>non audit\u00e9<\/strong><strong>)<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:446.55pt; border-collapse:collapse ;\">\n<tbody>\n<tr>\n<td rowspan=\"2\" style=\"width:321.34px;;text-align: justify ;  vertical-align: middle; vertical-align: middle ; text-align: justify ;  vertical-align: middle; \">En millions de dollars<\/p>\n<p>&nbsp;<\/td>\n<td colspan=\"2\" style=\"width:274.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>T<\/strong><strong>rois mois clos 31 mars<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>20<\/strong><strong>23<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>202<\/strong><strong>2<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>Produits <\/strong><strong>op\u00e9rationnels<\/strong><\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \"><strong>2.2<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \"><strong>2.5<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Recherche &amp; d\u00e9veloppement<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(16.0)<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(12.2)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Frais commerciaux<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(0.4)<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(0.5)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Frais g\u00e9n\u00e9raux<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(6.9)<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(6.6)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>Charges op\u00e9rationnelles<\/strong><\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>(<\/strong><strong>23.<\/strong><strong>3<\/strong><strong>)<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>(1<\/strong><strong>9.3<\/strong><strong>)<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">R\u00e9sultat financier<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">0.6<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">0,2<\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">Imp\u00f4t sur les soci\u00e9t\u00e9s<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">&#8211;<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \">(0.1)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>R\u00e9sultat net<\/strong><\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>(<\/strong><strong>20.<\/strong><strong>5<\/strong><strong>)<\/strong><\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>(<\/strong><strong>16.7<\/strong><strong>)<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:321.34px;;text-align: left ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">R\u00e9sultat de base et dilu\u00e9 par action ($\/action)<\/td>\n<td style=\"width:137px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">(0.22)<\/td>\n<td style=\"width:137.07px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">(0.30)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"left\"><strong>ETAT RESUME DU TABLEAU <\/strong><strong>DE FLUX DE TRESORERIE CONSOLIDE (<\/strong><strong>non audit\u00e9<\/strong><strong>)<\/strong><\/p>\n<table style=\"border-collapse: collapse; width:446.55pt; border-collapse:collapse ;\">\n<tbody>\n<tr>\n<td rowspan=\"2\" style=\"width:330.8px;;text-align: justify ;  vertical-align: middle; vertical-align: middle ; text-align: justify ;  vertical-align: middle; \">En millions de dollars<\/p>\n<p>&nbsp;<\/td>\n<td colspan=\"2\" style=\"width:264.6px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>T<\/strong><strong>rois<\/strong> <strong>mois clos mars 31<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>202<\/strong><strong>3<\/strong><\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>202<\/strong><strong>2<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:330.8px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Flux de tr\u00e9sorerie net li\u00e9 aux activit\u00e9s op\u00e9rationnelles<\/td>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">(20.8)<\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; vertical-align: middle ; \">(1.5)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:330.8px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Flux de tr\u00e9sorerie net li\u00e9 aux activit\u00e9s d\u2019investissement<\/td>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">&#8211;<\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">&#8211;<\/td>\n<\/tr>\n<tr>\n<td style=\"width:330.8px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Flux de tr\u00e9sorerie net li\u00e9 aux activit\u00e9s de financement<\/td>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">&#8211;<\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(0.1)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:330.8px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Incidence des variations du cours des devises<\/td>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">3.9<\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">(1.6)<\/td>\n<\/tr>\n<tr>\n<td style=\"width:330.8px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \"><strong>Augmentation\/(diminution) de la tr\u00e9sorerie<\/strong><\/td>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>(<\/strong><strong>1<\/strong><strong>6.9<\/strong><strong>)<\/strong><\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \"><strong>(<\/strong><strong>3.<\/strong><strong>2<\/strong><strong>)<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:330.8px;;text-align: left ;  vertical-align: middle; vertical-align: middle ; \">Tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie nets \u00e0 l\u2019ouverture<\/td>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">209.2<\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; vertical-align: middle ; \">77.3<\/td>\n<\/tr>\n<tr>\n<td style=\"width:330.8px;;text-align: left ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>Tr\u00e9sorerie et \u00e9quivalents de tr\u00e9sorerie nets \u00e0 la cl\u00f4ture<\/strong><\/td>\n<td style=\"width:132.27px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>192.3<\/strong><\/td>\n<td style=\"width:132.34px;;text-align: center ;  vertical-align: middle; border-top: solid black 1pt ; border-bottom: solid black 1pt ; vertical-align: middle ; \"><strong>7<\/strong><strong>4.1<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p align=\"justify\"><strong>\u00c0 propos de DBV Technologies<\/strong><br \/>DBV Technologies d\u00e9veloppe Viaskin\u2122, une plateforme technologique exclusive exp\u00e9rimentale avec de larges applications potentielles en immunoth\u00e9rapie. Viaskin est bas\u00e9 sur l\u2019immunoth\u00e9rapie \u00e9picutan\u00e9e, ou EPIT\u2122, et constitue la m\u00e9thode de DBV Technologies pour d\u00e9livrer des compos\u00e9s biologiquement actifs au syst\u00e8me immunitaire \u00e0 travers la peau intacte. Avec cette nouvelle classe de produits candidats non invasifs, la Soci\u00e9t\u00e9 vise \u00e0 transformer en toute s\u00e9curit\u00e9 le traitement des patients souffrant d\u2019allergies alimentaires. Les programmes de DBV Technologies sur les allergies alimentaires comprennent des essais cliniques en cours sur Viaskin Peanut. Le si\u00e8ge mondial de DBV Technologies est situ\u00e9 \u00e0 Montrouge, en France, et ses op\u00e9rations nord-am\u00e9ricaines sont bas\u00e9es \u00e0 Basking Ridge, NJ. Les actions ordinaires de la Soci\u00e9t\u00e9 sont n\u00e9goci\u00e9es sur le segment B d\u2019Euronext Paris (symbole : DBV, code ISIN: FR0010417345) et les ADS de la Soci\u00e9t\u00e9 (chacun repr\u00e9sentant une demi-action ordinaire) sont n\u00e9goci\u00e9s sur le Nasdaq Global Select Market (symbole : DBVT).<\/p>\n<p align=\"left\"><strong>D\u00e9clarations prospectives<\/strong><br \/>Ce communiqu\u00e9 de presse peut contenir des d\u00e9clarations et estimations prospectives, notamment des d\u00e9clarations concernant la situation financi\u00e8re et les d\u00e9marches cliniques pr\u00e9vues par DBV.. Ces d\u00e9clarations et estimations prospectives ne constituent ni des promesses ni des garanties, et comportent des risques et des al\u00e9as substantiels. \u00c0 ce stade, les produits candidats de DBV n\u2019ont \u00e9t\u00e9 autoris\u00e9s \u00e0 la vente dans aucun pays. Parmi les facteurs susceptibles de faire en sorte que les r\u00e9sultats r\u00e9els diff\u00e8rent sensiblement de ceux d\u00e9crits ou pr\u00e9vus dans ce document, peuvent \u00eatre cit\u00e9es, les incertitudes li\u00e9es de mani\u00e8re g\u00e9n\u00e9rale aux activit\u00e9s de recherche et de d\u00e9veloppement, aux essais cliniques, et aux examens et approbations r\u00e9glementaires correspondants, y compris l&rsquo;impact de la pand\u00e9mie de COVID-19 et la capacit\u00e9 de DBV \u00e0 mettre en \u0153uvre avec succ\u00e8s ses mesures de discipline budg\u00e9taire. Une liste d\u00e9taill\u00e9e et une description de ces risques, al\u00e9as et autres risques, qui pourraient engendrer que les r\u00e9sultats r\u00e9els diff\u00e8rent sensiblement de ceux indiqu\u00e9s dans les d\u00e9clarations prospectives du pr\u00e9sent communiqu\u00e9 de presse, figurent dans les documents d\u00e9pos\u00e9s par DBV aupr\u00e8s de l\u2019Autorit\u00e9 des March\u00e9s Financiers (\u00ab AMF \u00bb) au titre de ses obligations r\u00e9glementaires, dans les documents et rapports de la soci\u00e9t\u00e9 d\u00e9pos\u00e9s aupr\u00e8s de l\u2019Autorit\u00e9 de r\u00e9glementation et de contr\u00f4le des march\u00e9s financiers (\u00ab Securities and Exchange Commission \u00bb ou \u00ab SEC \u00bb) aux \u00c9tats-Unis, notamment dans le rapport annuel de DBV sur le formulaire 10-K relatif \u00e0 l\u2019exercice cl\u00f4tur\u00e9 le 31 d\u00e9cembre 2022, d\u00e9pos\u00e9 aupr\u00e8s de la SEC le 2 mars 2023, et dans les documents et rapports futurs publi\u00e9s par DBV aupr\u00e8s de l\u2019AMF et de la SEC. Les investisseurs existants et potentiels sont avertis qu\u2019ils ne doivent pas se fier ind\u00fbment \u00e0 ces d\u00e9clarations et estimations prospectives, qui ne valent qu\u2019\u00e0 la date des pr\u00e9sentes. Sauf lorsque cela est requis par la r\u00e9glementation applicable, DBV ne prend aucun engagement quant \u00e0 la mise \u00e0 jour ou \u00e0 la r\u00e9vision des informations contenues dans ce communiqu\u00e9 de presse.<\/p>\n<p align=\"justify\"><strong>Contact <\/strong><strong>r<\/strong><strong>elations <\/strong><strong>i<\/strong><strong>nvestisseurs<\/strong><br \/>Anne Pollak<br \/>+&nbsp;1&nbsp;(857)&nbsp;529-2363<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f3zFiXTyDxD_sfNNW-sRPB8NTQfiRppIG_ahd3RT_oID34iKN-u6FwoH8yzOkagfKiqZaPtUzSVC3SBB0k4XE0fZyGDGLjtyGDOSL50rih8hnBG8vl_DQ9Wq8oM4fBi2\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><u>anne.pollak@dbv-technologies.com<\/u><\/a><\/p>\n<p align=\"justify\"><strong>Contact m\u00e9dias<\/strong><br \/>Angela Marcucci<br \/>+1&nbsp;(646)&nbsp;842-2393<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ztSFRIBa23howjN1g0y5R3Nx1T5AotXIAR79ljucfCCo9pnGREdLjAFdhxDh0CAC6ApW6rt6BMXNK4sHmFmTEBvSmYwmUwrGqFHktSdRza5j14_avylGF7wTKxyUuQvrjy6_S8basyn8oMS3mNp_lA==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"angela.marcucci@dbv-technologies.com\">angela.marcucci@dbv-technologies.com<\/a><\/p>\n<\/p>\n<p id=\"gnw_attachments_section-header\">    <strong>Pi\u00e8ce jointe<\/strong><\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=6K8cdHg_Ec1bMQoheorZLU3Zle-ruW2bs2FMo7_UcXeoxNPZv8tq35ptZa1I3WXyNqtdSZ8alJvnhz1FGCDA8RwsjCrkFp4ygdXb4wzIrNMvQxc7pNFDL961HRRPwqL2x9Y7gINW8awloGoFAAwCHBi3GWuSLSLyDVQ1uhdhTJ0=\" title=\"version PDF\" rel=\"nofollow noopener\">version PDF<\/a>      <\/li>\n<\/ul>\n<p><img decoding=\"async\" data-src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZDFmYTA0ZGEtODJiMy00NTA5LWJmZWYtNWUzMzJkNTYyZjMyLTEwMTExNTI=\/tiny\/DBV-Technologies-S-A-.png\" referrerpolicy=\"no-referrer-when-downgrade\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\">        <\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"wds_primary_press_release_type":0,"footnotes":""},"press_release_type":[],"class_list":["post-13098","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/13098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/types\/press_releases"}],"version-history":[{"count":0,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_releases\/13098\/revisions"}],"wp:attachment":[{"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/media?parent=13098"}],"wp:term":[{"taxonomy":"press_release_type","embeddable":true,"href":"https:\/\/dbv-technologies.com\/fr\/wp-json\/wp\/v2\/press_release_type?post=13098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}